|
https://www.grants.gov/web/grants/search-grants.html?keywords=Coronavirus
|
|
Updated: 10/23/2020 (all new/revised opportunities listed first)
|
|
|
|
Agency
|
Opp Number
|
Name of solicitation
|
Application Due Date
|
Notes
|
|
NEW/REVISED
|
|
|
|
|
|
BARDA
|
BARDA-BAA
|
Advanced development and licensure of COVID-19 diagnostics, vaccines or medicines, such as therapeutics or antivirals.
|
4/30/2020
|
Added due date
|
|
CDC
|
75D301-20-R-67897
|
Broad Agency Announcement (BAA) Applied Research to Address The Coronavirus (COVID-19)
Emerging Public Health Emergency
|
03/25/2020
|
Immediate call for White papers.
|
|
NIAID
|
NIAID-BAA2020-1
|
2020 NIAID Omnibus Broad Agency Announcement
|
04/09/2020
|
Extended deadlines in specific areas only
|
|
NIAID
|
NOT-AI-20-030
|
Availability of Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus (2019-nCoV)
|
----------
|
Rolling deadlines
|
|
NIAID
|
RFA-AI-20-028
|
Partnerships for Countermeasures against Select Pathogens (R01 Clinical Trials Not Allowed)
|
06/29/2020
|
Mandatory LOI due 05/29/2020
|
|
NIAID
|
PAR-18-781
|
Collaborative Cross (CC) Mouse Model Generation and Discovery of Immunoregulatory Mechanisms (R21 Clinical Trial Not Allowed)
|
09/09/2020
|
|
|
NIDA
|
NOT-DA-20-047
|
Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus
|
-------
|
Supplement to existing awards.
Rolling deadlines. Especially interested in research collecting and examining data on the risks and outcomes for COVID-19 infection in individuals suffering from substance use disorders.
|
|
NHLBI
|
NOT-HL-20-757
|
Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19)
|
------
|
Supplement to existing awards.
Rolling deadlines. Topics of specific interest to NHLBI include SARS-CoV-2 host response, associations with heart, lung, and blood (HLB) diseases, potential impacts on transfusion safety, and clinical outcomes of infected individuals.
|
|
NIA
NIAID
NIDDK
NIDA
NIMH
NIEHS
NICHD
NIAAA
|
PA-18-935
|
Urgent Competitive Revision to Existing NIH Grants and Cooperative Agreements (Urgent Supplement - Clinical Trial Optional)
|
------
|
Continuous submission. Earliest start dates may vary by awarding IC. See the Urgent Guide Notices for any applicable Application Due Dates.
|
|
NIAID
NIA
|
PAR-20-139
|
Investigator Initiated Extended Clinical Trial (R01 Clinical Trial Required)
|
05/13/2020
|
|
|
NIHR (UK)
|
Travel Funds
|
Travel and subsistence funding to support delivery of technical expertise in the global response to Covid-19.
|
05/30/2020
|
Continuous submission. For UK collaborations only
|
|
|
|
|
|
|
|
Previous Postings
|
|
|
|
|
|
HHS-CDC-OSTLTS
|
CDC-RFA-OT18-18020202SUPP20
|
Strengthening Public Health Systems and Services through National Partnerships to Improve and Protect the Nations Health
|
04/02/2020
|
|
|
DOE
|
Dear Colleague Letter
|
DOE mission complements the efforts of the National Institutes of Health, the Department of Defense, and other Federal partners by helping to understand the scientific phenomena contributing to COVID-19, from the structure of the SARS-CoV-2 virus, which causes the disease, to models that can mimic its spread.
|
Responses accepted starting March 18, 2020
|
|
|
HHS-CDC-CGH
|
CDC-RFA-GH20-2113
|
Expanding Efforts and Strategies to Protect and Improve Public Health inVietnam
|
5/11/2020
|
|
|
HHS-CDC-CGH
|
CDC-RFA-GH20-2125
|
Enhancing Global Health Security: Expanding Efforts and Strategies to Protect and Improve Public Health in the Democratic Republic of the Congo (DRC)
|
5/12/2020
|
|
|
HHS-CDC-OSTLTS*
|
CDC-RFA-OT18-18020202SUPP20
|
Strengthening Public Health Systems and Services through National Partnerships to Improve and Protect the Nations Health
|
4/2/2020
|
|
|
HHS-CDC-CGH
|
CDC-RFA-GH20-2124
|
Improving Health Security and Building International Health Regulations core capacities in the Republic of Uganda
|
5/12/2020
|
|
|
HHS-CDC-CGH
|
CDC-RFA-GH20-2115
|
Expanding Efforts and Strategies to Protect and Improve Public Health in Kenya
|
5/11/2020
|
|
|
HHS-CDC-CGH
|
CDC-RFA-GH20-2118
|
Global Health Security through Strengthened Community Based Surveillance
|
5/11/2020
|
|
|
HHS-CDC-CGH
|
CDC-RFA-GH20-2131
|
Strengthening Regional Field Epidemiology Training Program (FETP) Networks
|
5/4/2020
|
|
|
HHS-CDC-CGH
|
CDC-RFA-GH20-2119
|
Global Health Security Partner Enhancement : Expanding Efforts to Improve Surveillance and Laboratory Data Interoperability
|
5/4/2020
|
|
|
DHHS/CDC
|
CDC-RFA-OT18-18020202SUPP20
|
Strengthening Public Health Systems and Services through National Partnerships to Improve and Protect the Nations Health
|
3/20/2020
|
|
|
USAID
|
7200AA20RFA00007
|
STOP Spillover
|
N/A
|
|
|
DHHS/CDC
|
CDC-RFA-GH20-2093
|
Protecting and Improving Public Health Globally: Building and Strengthening Public Health Impact, Health Systems, Capacity Building, and Health Security in Cote d’Ivoire
|
04/07/20 11:59 ET
|
|
|
DHHS/CDC
|
CDC-RFA-GH20-2094
|
Advancing Ethiopia's Capacity for Laboratory, Workforce Development, Surveillance, and Emergency Management to meet International Health Regulations requirements
|
04/07/2020 11:59 ET
|
|
|
DHHS/CDC
|
CDC-RFA-GH20-2095
|
Strengthening Laboratory Systems to Establish Routine Laboratory based surveillance for Priority Infectious Diseases in India
|
04/27/2020 11:59 ET
|
|
|
DHHS/CDC
|
CDC-RFA-GH20-2108
|
Strengthening Global Field Epidemiology Training Program (FETP) Network
|
04/27/2020 11:59 ET
|
|
|
DHHS/CDC
|
CDC-RFA-GH20-2107
|
Building Capacity for National Public Health Institutes
|
5/4/2020
|
|
|
DHHS/CDC
|
CDC-RFA-GH20-2109
|
Global Health Security Partnerships: Expanding and Improving Public Health Laboratory Strategies and Systems.
|
5/4/2020
|
|
|
DHHS/CDC
|
CDC-RFA-GH20-2122
|
Strengthening Sustainability of Global Health Security Objectives in Sierra Leone
|
5/4/2020
|
|
|
DHHS/CDC
|
CDC-RFA-GH20-2092
|
Global Health Security Partnership Engagement: Expanding Efforts and Strategies to Protect and Improve Public Health in Cameroon
|
4/7/2020
|
|
|
DHHS/CDC
|
CDC-RFA-GH20-2126
|
Strengthening Global Health Security by implementation of the International Health Regulations (IHR) (2005) and the Global Health Security Agenda in Nigeria
|
4/27/2020
|
|
|
DHHS/CDC
|
CDC-RFA-GH20-2110
|
Enhancing Global Health Security: Expanding Efforts and Strategies to Protect and Improve Public Health Globally
|
4/27/2020
|
|
|
DHHS/CDC
|
CDC-RFA-GH20-2091
|
Accelerating Sustainability of Public Health Systems in India to Prevent, Detect, and Respond to Infectious Disease Outbreaks and Other Public Health Emergencies
|
4/27/2020
|
|
|
DHHS/CDC
|
CDC-RFA-GH20-2101
|
Tanzania Global Health Security Partner Engagement: Advancing Efforts and Strategies to Protect and Improve Public Health
|
4/27/2020
|
|
|
HHS-NIH11
|
RFA-AI-20-009
|
Three-Dimensional (3D) Human Biomimetics for Infectious Diseases (U19 Clinical Trial Not Allowed)
|
5/29/2020
|
|
|
HHS-CDC-CGH
|
CDC-RFA-GH20-2095
|
Strengthening Laboratory Systems to Establish Routine Laboratory based surveillance for Priority Infectious Diseases in India
|
4/27/2020
|
|
|
HHS-NIH11
|
PAR-20-108
|
International Research in Infectious Diseases (R01 Clinical Trial Not Allowed)
|
8/19/2022
|
|
|
NIH Funding
|
|
|
|
|
|
NIH/NIAID/NIA
|
PAR-20-139
|
Invites applications for implementation of investigator-initiated clinical trials requiring an extended project period of 6 or 7 years. The trials can be any phase, must be hypothesis-driven, and related to the research mission of one of the participating ICs.
|
05/13/2020
|
|
|
NIH/NIAID/ NIGMS
|
NOT-AI-20-030
|
Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus (2019-nCoV)
|
Immediate
|
|
|
NIH/NIAID
|
RFA-AI-20-021
|
Vaccine and Treatment Evaluation Units (VTEUs): Enhancing Capability and Capacity (UM1 Clinical Trial Required)
|
04/14/2020
|
|
|
NIH/NIAID
|
RFA-AI-20-009
|
Three-Dimensional (3D) Human Biomimetics for Infectious Diseases (U19 Clinical Trial Not Allowed)
|
05/29/2020
|
|
|
NIH/NIAID
|
RFA-AI-20-003
|
Partnerships for the Development of Universal Influenza Vaccines (R21/R33 Clinical Trial Not Allowed)
|
06/02/2020
|
|
|
NIH/NIAID
|
RFA-AI-20-008
|
Multidisciplinary Studies to Improve Understanding of Influenza Transmission (U19 Clinical Trial Optional)
|
06/23/2020
|
|
|
NIH/Multiple Institutes
|
PA-18-591
|
Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)
|
Contact Program Officer
|
|
|
NIH/Fogarty International Center
|
|
Ecology and Evolution of Infectious Diseases Initiative (EEID)
|
11/18/2020
|
|
|
OTHER FEDERAL AGENCIES
|
|
|
|
|
NSF
|
Letter to Researchers
|
To conduct non-medical, non-clinical-care research that can be used immediately to explore how to model and understand the spread of COVID-19, to inform and educate about the science of virus transmission and prevention, and to encourage the development of processes and actions to address this global challenge.
|
Immediate
|
|
|
PRIVATE FUNDING
|
|
|
|
|
Bill & Melinda Gates Foundation, Wellcome, and Mastercard COVID-19 Therapeutics Accelerator
|
|
$125 million to speed-up the response to the COVID-19 epidemic by identifying, assessing, developing, and
scaling-up treatments.
|
|
|